Treatment of idiopathic generalized epilepsy – a review of the evidence

Bibliography

• Engel J Jr. Seizures and Epilepsy, Contemporary Neurology Series. Volume 31 FA Davis; Philadelphia, PA: 1989
   Google Scholar
• Mattson RH. Overview: idiopathic generalized epilepsies. Epilepsia 2003;44(Suppl 2):2-6
   PubMed Web of Science ®Google Scholar
• Fisher RS, van Emde Boas W, Blume W, Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2
   PubMed Web of Science ®Google Scholar
• Fisher RS, Leppik I. Debate: when does a seizure imply epilepsy? Epilepsia 2008;49(Suppl 9):7-12
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501
   PubMed Web of Science ®Google Scholar
• Engel J Jr. Classification of epileptic disorders. Epilepsia 2001;42:316
   PubMed Web of Science ®Google Scholar
• Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99
   PubMed Web of Science ®Google Scholar
• Berg AT, Berkovic SF, Brodie MJ, Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005 – 2009. Epilepsia 2010;51:676-85
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician's critical view and contribution. Epilepsia 2011;52:2155-60
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. Idiopathic generalized epilepsies: a review and modern approach. Epilepsia 2005;46(Suppl 9):1-6
   PubMed Web of Science ®Google Scholar
• Koutroumanidis M, Smith S. Use and abuse of EEG in the diagnosis of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):96-107
   PubMed Web of Science ®Google Scholar
• Villarreal HJ, Wilder BJ, Willmore LJ, Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 1978;28:886
   PubMed Web of Science ®Google Scholar
• Callaghan N, O'Hare J, O'Driscoll D, Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (Petit Mal). Dev Med Child Neurol 1982;24:830-6
   PubMed Web of Science ®Google Scholar
• Sato S, White BG, Penry JK, Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63
   PubMed Web of Science ®Google Scholar
• Hitiris N, Brodie MJ. Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. Epilepsia 2005;46(Suppl 9):149-53
   PubMed Web of Science ®Google Scholar
• Zimmerman FT, Burgemeister BB. A new drug for petit mal epilepsy. Neurology 1958;8:769-75
   PubMed Web of Science ®Google Scholar
• Heathfield KW, Jewesbury EC. Treatment of petit mal with ethosuximide. Br Med J 1961;2:565-7
   PubMed Web of Science ®Google Scholar
• Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720
   PubMed Web of Science ®Google Scholar
• Dulac O, Steru D, Rey E, Sodium valproate (Na VPa) monotherapy in childhood epilepsy. Arch Fr Pediatr 1982;39:347-52
   PubMedGoogle Scholar
• Bourgeois B, Beaumanoir A, Blajev B, Monotherapy with valproate in primary generalized epilepsies. Epilepsia 1987;28(Suppl 2):S8-11
   PubMed Web of Science ®Google Scholar
• Gelisse P, Genton P, Kuate C, Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004;45:1282-6
   PubMed Web of Science ®Google Scholar
• Benbadis SR, Tatum WOT, Gieron M. Idiopathic generalized epilepsy and choice of antiepileptic drugs. Neurology 2003;61:1793-5
   PubMed Web of Science ®Google Scholar
• Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):10-14
   PubMed Web of Science ®Google Scholar
• Manford M, Hart YM, Sander JW, The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol 1992;49:801-8
   PubMedGoogle Scholar
• Gastaut H, Gastaut JL, Goncalves e Silva GE, Relative frequency of different types of epilepsy: a study employing the classification of the International League Against Epilepsy. Epilepsia 1975;16:457-61
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP. A Clinical Guide to Epileptic Syndromes and their Treatment. 2nd edition. Springer; London: 2007
   Google Scholar
• Sadleir LG, Scheffer IE, Smith S, EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state. Epilepsia 2009;50:1572-8
   PubMed Web of Science ®Google Scholar
• Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):48-56
   PubMed Web of Science ®Google Scholar
• Commission on Pediatric Epilepsy of the International League Against Epilepsy. Myoclonus and epilepsy in childhood. Epilepsia 1997;38:1251-4
   PubMedGoogle Scholar
• Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):57-66
   PubMed Web of Science ®Google Scholar
• Guerrini R, Parmeggiani L, Marini C, Autosomal dominant cortical myoclonus and epilepsy (ADCME) with linkage to chromosome 2p11.1-q12.2. Adv Neurol 2005;95:273-9
   PubMedGoogle Scholar
• Striano P, Zara F, Striano S. Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand 2005;111:211-17
   PubMed Web of Science ®Google Scholar
• Callenbach PM, Geerts AT, Arts WF, Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: dutch Study of Epilepsy in Childhood. Epilepsia 1998;39:331-6
   PubMed Web of Science ®Google Scholar
• Berg AT, Levy SR, Testa FM, Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999;40:439-44
   PubMed Web of Science ®Google Scholar
• Adie WJ. Pyknolepsy: a form of epilepsy in children, with a good prognosis. Proc R Soc Med 1924;17:19-25
   PubMedGoogle Scholar
• Loiseau J, Panayiotopoulos P. Childhood absence epilepsy [Internet]. 2000. Available from: http://www.ilae-epilepsy.org/ctf/childhood_absence.html [last accessed June 2011]
   Google Scholar
• Panayiotopoulos CP, Obeid T, Waheed G. Differentiation of typical absence seizures in epileptic syndromes. A video EEG study of 224 seizures in 20 patients. Brain 1989;112:1039-56
   PubMed Web of Science ®Google Scholar
• Glauser T, Ben-Menachem E, Bourgeois B, ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:10941-20
   Web of Science ®Google Scholar
• Beydoun A, Milling CJ. Active-control comparative equivalency monotherapy trials in epilepsy: are they scientifically valid? Epilepsy Behav 2001;2:187-92
   PubMed Web of Science ®Google Scholar
• Glauser TA, Cnaan A, Shinnar S, Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-9
   PubMed Web of Science ®Google Scholar
• Arroyo S, Dodson WE, Privitera MD, Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005;112:214-22
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Richens A, Yuen AW; UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9
   PubMed Web of Science ®Google Scholar
• Frank LM, Enlow T, Holmes GL, Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9
   PubMed Web of Science ®Google Scholar
• Steinhoff BJ, Ueberall MA, Siemes H, The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Seizure 2005;14:597-605
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26
   PubMed Web of Science ®Google Scholar
• Fattore C, Boniver C, Capovilla G, A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 2011;52:802-9
   PubMed Web of Science ®Google Scholar
• Canger R, Guidolin L. Clinical efficacy and tolerability of magnesium valproate as monotherapy in patients with generalised or partial epilepsy: a nonblinded study of 320 patients. Clin Drug Investig 2000;20:215-21
   Web of Science ®Google Scholar
• Genton P, Gelisse P, Thomas P, Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Chadwick DW, Anhut H, Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000
   PubMed Web of Science ®Google Scholar
• Nicolson A, Appleton RE, Chadwick DW, The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 2004;75:75-9
   PubMed Web of Science ®Google Scholar
• Guerrini R, Carpay J, Groselj J, Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Seizure 2005;14:371-80
   PubMed Web of Science ®Google Scholar
• Mohanraj R, Brodie MJ. Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav 2005;6:382-7
   PubMed Web of Science ®Google Scholar
• Wilfong A, Schultz R. Zonisamide for absence seizures. Epilepsy Res 2005;64:31-4
   PubMed Web of Science ®Google Scholar
• Bauer J, Buchmuller L, Reuber M, Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy. Acta Neurol Scand 2008;117:55-9
   PubMed Web of Science ®Google Scholar
• Nejad S, Nikpour M, Rahim F, A randomized open-label comparison of lamotrigine and valproate in patients with juvenile myoclonic epilepsy. Int J Pharmacol 2009;5:313-18
   Google Scholar
• Lombroso CT, Forxythe I. A long-term follow-up of acetazolamide (diamox) in the treatment of epilepsy. Epilepsia 1960;1:493-500
   PubMed Web of Science ®Google Scholar
• Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990;40:1677-81
   PubMed Web of Science ®Google Scholar
• Atakli D, Sozuer D, Atay T, Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998;7:63-6
   PubMed Web of Science ®Google Scholar
• Holland KD, Monahan S, Morita D, Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand 2010;121:149-53
   PubMed Web of Science ®Google Scholar
• Biton V, Montouris GD, Ritter F, A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-7
   PubMed Web of Science ®Google Scholar
• Biton V, Sackellares JC, Vuong A, Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005;65:1737-43
   PubMed Web of Science ®Google Scholar
• Trevathan E, Kerls SP, Hammer AE, Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics 2006;118:e371-8
   Web of Science ®Google Scholar
• Biton V, Di Memmo J, Shukla R, Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav 2010;19:352-8
   PubMed Web of Science ®Google Scholar
• Berkovic SF, Knowlton RC, Leroy RF, Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-60
   PubMed Web of Science ®Google Scholar
• Noachtar S, Andermann E, Meyvisch P, Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-16
   PubMed Web of Science ®Google Scholar
• Beran RG, Berkovic SF, Dunagan FM, Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 1998;39:1329-33
   PubMed Web of Science ®Google Scholar
• Golla FL, Hodge RS. Control of petit mal by acetazolamide. J Ment Sci 1957;103:214-17
   PubMed Web of Science ®Google Scholar
• Mikkelsen B, Birket-Smith E, Bradt S, Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch Neurol 1976;33:322-5
   PubMedGoogle Scholar
• Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2005;4:CD003032
   Google Scholar
• Adab N, Kini U, Vinten J, The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
   PubMed Web of Science ®Google Scholar